
Monday, June 22, 2020 12:53:20 PM
Recent KPTI News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 09:13:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 09:54:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 09:52:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 09:51:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 09:49:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 09:46:17 PM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 03/03/2025 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/24/2025 09:16:55 PM
- Karyopharm Announces 1-for-15 Reverse Stock Split • PR Newswire (US) • 02/24/2025 01:40:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2025 09:17:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2025 12:32:17 PM
- Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results, Announces Update to Phase 3 XPORT-EC-042 Trial and Highlights Recent Company Progress • PR Newswire (US) • 02/19/2025 12:30:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/12/2025 02:36:58 PM
- Karyopharm to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 • PR Newswire (US) • 02/12/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2025 09:16:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2025 09:15:35 PM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 02/03/2025 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2025 09:05:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2025 09:06:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 01:34:48 PM
- Karyopharm Announces Preliminary Unaudited 2024 Revenue and 2025 Objectives • PR Newswire (US) • 01/13/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2025 09:03:20 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2025 10:07:56 PM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 01/02/2025 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2025 12:08:18 PM
UAV Corp. to Present Critical Inflation Test in 30 Days, Paving the Way to Secure Over $525 Million in DART Series Sales Contracts • UMAV • Mar 14, 2025 1:00 PM
Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance • FITY • Mar 14, 2025 10:30 AM
WIN-LIGHT GLOBAL FILES SEC SCHEDULE 13G DISCLOSING 1.96M SHARES OF PASSIVE INSTITUTIONAL INVESTOR OWNERSHIP • CNTM • Mar 14, 2025 7:13 AM
The Crypto Company Expands Leadership Team With Experienced Financial and Blockchain Professionals • CRCW • Mar 13, 2025 9:23 AM
ConnectM Announces $10 Million Share Repurchase Program • CNTM • Mar 13, 2025 9:13 AM
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making • SIGY • Mar 12, 2025 9:41 AM